TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Smerud Medical Research Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,047
|
2,114
|
611 |
| Financial expenses |
0
|
0
|
2 |
| Earnings before taxes |
1,190
|
586
|
-462 |
| EBITDA |
1,189
|
581
|
-460 |
| Total assets |
2,339
|
1,968
|
1,790 |
| Current assets |
2,339
|
1,968
|
1,790 |
| Current liabilities |
426
|
1,258
|
1,673 |
| Equity capital |
1,913
|
710
|
116 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.8%
|
36.1%
|
6.5% |
| Turnover per employee |
3,047
|
2,114
|
611 |
| Profit as a percentage of turnover |
39.1%
|
27.7%
|
-75.6% |
| Return on assets (ROA) |
50.9%
|
29.8%
|
-25.7% |
| Current ratio |
549.1%
|
156.4%
|
107.0% |
| Return on equity (ROE) |
62.2%
|
82.5%
|
-398.3% |
| Change turnover |
895
|
1,460
|
416 |
| Change turnover % |
42%
|
223%
|
214% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.